Resmed Inc
F:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
F:RME
|
US |
|
F
|
First Pacific Co Ltd
XMUN:FPC
|
HK |
|
G
|
Guangxi Energy Co Ltd
SSE:600310
|
CN |
|
W
|
Weatherford International PLC
F:0WE
|
US |
|
D
|
Dental Patient Care America Inc
OTC:DPAT
|
US |
|
M
|
Moorim Paper Co Ltd
KRX:009200
|
KR |
|
Tomoe Corp
TSE:1921
|
JP |
|
D
|
Danaher Corp
F:DAP
|
US |
|
M
|
Mitie Group PLC
F:MZ4
|
UK |
|
P
|
Pensionbee Group PLC
LSE:PBEE
|
UK |
Intrinsic Value
Is RME undervalued or overvalued?
See the intrinsic value estimate for 
Resmed Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
RME looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with RME’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Resmed Does
Resmed makes devices and software for people with sleep apnea, COPD, and other breathing disorders. Its main products are CPAP and bilevel machines, masks, and other patient interface products that help people breathe more easily at home while they sleep. It also sells cloud-connected software that helps doctors, sleep clinics, and home medical equipment providers track treatment and manage patients.
- Headquarters
- United States of America US
- Employees
- 10 600
- IPO date
- Jun 1, 1995
Resmed has a narrow economic moat
Patents limit direct copying of Resmed’s breathing devices and masks, while its software makes replacing established care systems time-consuming. These protections help it retain customers, although rivals can still compete with different product designs.
Read the full moat analysis
Revenue & Expenses Breakdown
Resmed Inc
Earnings Waterfall
Resmed Inc
The intrinsic value for Resmed Inc (RME) under the Base Case is hidden EUR.
Compared with the current market price of 223 EUR, the stock appears hidden.